Ausgabe 12/2014
Inhalt (11 Artikel)
Glucagon and Type 2 Diabetes: the Return of the Alpha Cell
Asger Lund, Jonatan I. Bagger, Mikkel Christensen, Filip K. Knop, Tina Vilsbøll
Bone as an Endocrine Organ Relevant to Diabetes
Sarah L. Booth, Amanda J. Centi, Caren Gundberg
Lifestyle Interventions to Reduce Diabetes and Cardiovascular Disease Risk Among Children
Dorothy J. Van Buren, Tiffany L. Tibbs
Community Health Worker Interventions for Latinos With Type 2 Diabetes: a Systematic Review of Randomized Controlled Trials
Tariana V. Little, Monica L. Wang, Eida M. Castro, Julio Jiménez, Milagros C. Rosal
Stem Cell Therapy to Treat Heart Ischaemia: Implications for Diabetes Cardiovascular Complications
Abbas Ali Qayyum, Anders Bruun Mathiasen, Jens Kastrup
Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes
Michelle Rosenzwajg, Guillaume Churlaud, Agnès Hartemann, David Klatzmann
Extracellular Matrix Components in the Pathogenesis of Type 1 Diabetes
Marika Bogdani, Eva Korpos, Charmaine J. Simeonovic, Christopher R. Parish, Lydia Sorokin, Thomas N. Wight
Type 2 Diabetes Pharmacoepidemiology Update 2014: Safety Versus Efficacy
Sonal Singh
The Charcot Foot as a Complication of Diabetic Neuropathy
Janice V. Mascarenhas, Edward B. Jude
Shared Neurobiological Pathways Between Type 2 Diabetes and Depressive Symptoms: a Review of Morphological and Neurocognitive Findings
Todd Doyle, Angelos Halaris, Murali Rao
Glucokinase MODY and Implications for Treatment Goals of Common Forms of Diabetes
Ramzi A. Ajjan, Katharine R. Owen